Jackob Moskovitz

Jackob Moskovitz

Apr 13, 2019

Group 6 Copy 222
-1
    Please wait...

    About This Project

    Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Do human activities increase antibiotic-resistant disease in Chilean penguins?

    Penguins are suffering population declines due to a variety of human causes, including disease. One indicator...

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Campaign Ended

    A medicine project funded by 45 people